It is an honour to follow the hon. Member for Bristol East (Kerry McCarthy). I congratulate the hon. Member for Wakefield (Mary Creagh) on calling this debate on behalf of the Opposition, but I think there will be genuine disappointment in the countryside that the terms of the motion before the House are:
“That this House believes the badger cull should not go ahead”,
and yet the Opposition did not suggest any alternatives. Those who genuinely believe that a badger cull should not go ahead must provide alternative ways to control the spread of TB in cattle. So I am very persuaded by what my right hon. Friend the Secretary of State said in setting out his proposals for a package of measures to limit the movement of cattle and increase rigorous testing.
I shall focus my limited remarks on vaccination. I thank all those witnesses, including Ministers, who, in an incredibly short period, gave so generously of their time to respond to our Select Committee inquiry, and to colleagues for accommodating the very tight timetable. We concluded that vaccination is no magic bullet in the search for a solution to bovine TB. As the Secretary of State said, this is a bacterium that affects humans, and I have had family members just one generation ago who suffered from TB with lifelong consequences. In the report, we warn that vaccination is expensive, offers no guarantee of protection and will provide little benefit in the immediate future.
I shall cover some of the points linked to cattle vaccination. We commend the investment by successive Governments—the hon. Member for Wakefield referred to her own, my right hon. Friend the Secretary of State to current investment—but there are many hurdles to overcome. The European Commission evidence before the Committee, both in writing and orally, clearly set out that there is an indicative timetable of a 10-year period before vaccination will be operational.
There are other issues. We need to change the legislation. We need to negotiate with both the European Union and the World Organisation for Animal Health, which is known as the OIE, so that those cattle that have been injected, and their products, will be admitted in free circulation in other member states. That is the dilemma that many farmers will face. The hon. Member for Wakefield did not address the fact that when a vaccine becomes readily available, we will need to persuade farmers—cost issues aside—that it is in their interests to vaccinate. We need a cross-party approach to ensure that we use all lines of communication in those negotiations with the Commission.
It is important to factor in a cattle vaccine cost of £5 to £6 a dose. The DIVA test will cost an additional £25, which at least will show whether an animal is reacting to the vaccine or is infected. As regards badger vaccination, it is regrettable that there is no evidence to date to show that it reduces the incidence of TB in cattle. We are uncertain as yet of the implications for herd immunity. One of the Select Committee’s key recommendations, which I hope the Secretary of State will pursue, is that an advisory service be set up to help NGOs and charities plan and deploy vaccination. We also hope he will respond to our plea to allow farmers to become trained vaccinators and inject the vaccine. We worked out that only 25% of badgers would face a reduced risk of infection if vaccinated, so we emphasise that Government research is urgently needed to provide confidence in the level of efficacy to enable such a vaccine to be used strategically.
The development of an effective oral vaccine for badgers seems fraught with challenges. The cost is £6 million of research since 2005-06, with another £7.5 million allocated in the next five years, but we must be aware that no vaccine is ready for use yet. We urge the public to be aware that there is a mismatch between the public expectation of having a vaccine available and the current state of scientific evidence. A vaccine must be cost-effective and easy to deploy.
I should also refer to the importance and costs of testing—of the skin test, which costs £3, and the diagnostic blood test, which is £30—and some of the difficulties
that we highlighted in our report. It is very difficult sometimes to ascertain, from the skin test alone, whether an animal is infected.
All of us are badger-lovers, but we want a healthy badger population. I repeat that we are the only country to have given the badger protected status, and we must now live with the consequences, mindful of the fact that a badger who suffers TB will be evicted from the sett and die a particularly grisly death.
1.49 pm